Senior Consultant / Head of Division 100 %

Stem Cell Transplantation

Your responsibilities

• Programme leadership & platform: overall responsibility for the Cellular Therapies platform and leadership of the SCT Division, in close collaboration with the relevant clinical disciplines, including Hematology, Oncology, Immunology and Metabolic Medicine, to further develop autologous/allogeneic SCT and cellular therapies (CAR-T, gene and other advanced cell therapies).
• JACIE programme leadership: direction of the JACIE-/EBMT-accredited centre across all domains (CIC 334, Clinics, Collection, Processing, IES) under QM guidelines. GMP laboratory in cooperation with the GMP laboratory management.
• Strategy & networking: securing the national centre function and international integration (EBMT, SIOPE, IBFM, ITCC, ESID, NCCR Children & Cancer).
• Collaboration: cooperation, including interdisciplinary processes, with Hematology, Oncology, lmmunology, Rheumatology, Neurology and Metabolism, as well as with referring centres, registries, specialist organisations and authorities (Federal Office of Public Health, Swissmedic).
• Research: laboratory space at the Children's Research Centre is available for a research group. Excellent re-search environment.
• Innovation & translation: joint clinical & JACIE lead for GMP lab. Introduction of new procedures, e.g. graft processing, immunomodulation, ex-vivo/ in-vivo cell engineering, alternative conditioning regimens and cellular therapies for malignant and non-malignant indications (immunotherapies, gene therapies). Clinical trials & IITs: participation in international clinical trials (EBMT, JACIE, etc.) and development of own investigator-initiated trials (IITs).
• Leadership & Talent: fostering an interdisciplinary and interprofessional team of physicians (FTE 5.6), scientists (FTE 5.2) and nursing staff (FTE 15). Support of early-career researchers.

Your profile

• Specialist title: Pediatrics (FMH or equivalent) with a focus in pediatric Hematology/Oncology and/or clinical immunology; recognition of the title in Switzerland.
• Clinical expertise & experience: high motivation for the comprehensive care of patients and families. Broad experience in indication, delivery and follow-up of all forms of SCT and CT in malignant and non-malignant disease; including collection (bone-marrow harvest, apheresis). Long-standing clinical experience in managing the complications of SCT. Experience with Immunotherapies (scientific or clinical leadership with advanced cellular therapies.
• Quality systems: sound experience with JACIE, GCP and GMP guidelines.
• Leadership & team competence: a collaborative leadership style; combining strategic programme development with daily clinical practice. Experience and qualification in clinical management.
• Research: strong track record in translational or clinical research with third-party funding and independent research group.
• Languages: good German (or a commitment to acquire it within two years) and fluent scientific English; French/Italian an advantage.
• Service: participation in the SCT on-call service of the Department.

Kinderspital Zürich as an employer

Kinderspital Zürich is the largest university children's hospital in Switzerland with about 2,500 employees, and is one of the leading centres for paediatric and youth medicine in Europe. Although the hospital may be big, it's the little ones that count: up to 100,000 patients are cared for each year across 47 faculties, where we do everything in our power to ensure their well being. 'Kispi' not only offers cutting-edge devices and the highest quality of care, but also a good sense of interpersonal issues. Alongside its comprehensive range of paediatric medicine and surgery facilities, the children's hospital also offers a unique rehabilitation centre and a research centre.

Your estimated gross salary for a 100% position should fall between CHF 250'000 and CHF 260'000 per year.

Prof. Dr. med. Jean-Pierre Bourquin
Chief Physician
Telefonnummer auf jobs.nzz.ch ansehen

• Programme leadership & platform: overall responsibility for the Cellular Therapies platform and leadership of the SCT Division, in close collaboration with the relevant clinical disciplines, including Hematology, Oncology, Immunology and Metabolic Medicine, to further develop autologous/allogeneic SCT and cellular therapies (CAR-T, gene and other advanced cell therapies).
• JACIE programme leadership: direction of the JACIE-/EBMT-accredited centre across all domains (CIC 334, Clinics, Collection, Processing, IES) under QM guidelines. GMP laboratory in cooperation with the GMP laboratory management.
• Strategy & networking: securing the national centre function and international integration (EBMT, SIOPE, IBFM, ITCC, ESID, NCCR Children & Cancer).
• Collaboration: cooperation, including interdisciplinary processes, with Hematology, Oncology, lmmunology, Rheumatology, Neurology and Metabolism, as well as with referring centres, registries, specialist organisations and authorities (Federal Office of Public Health, Swissmedic).
• Research: laboratory space at the Children's Research Centre is available for a research group. Excellent re-search environment.
• Innovation & translation: joint clinical & JACIE lead for GMP lab. Introduction of new procedures, e.g. graft processing, immunomodulation, ex-vivo/ in-vivo cell engineering, alternative conditioning regimens and cellular therapies for malignant and non-malignant indications (immunotherapies, gene therapies). Clinical trials & IITs: participation in international clinical trials (EBMT, JACIE, etc.) and development of own investigator-initiated trials (IITs).
• Leadership & Talent: fostering an interdisciplinary and interprofessional team of physicians (FTE 5.6), scientists (FTE 5.2) and nursing staff (FTE 15). Support of early-career researchers.